📣 CALL FOR PAPERS-Climate Change
Showcasing papers that investigate the mechanisms by which environmental climate change-related factors impact lung health and disease
Deadline is October 1, 2024
More information here:
https://t.co/EPGUe2AguM?
📣 CALL FOR PAPERS-From Multi-Omics to Mechanisms of Lung Disease 📣
Focusing on the use and impact of multiple omics technologies associated with respiratory diseases, lung development, and precision medicine strategies.
Deadline is March 1, 2024
https://t.co/W2US6EgfPu
#WeekendRead! #InterferonPower ! Fessler &co show @jclinicalinvest that IRGM1 prevents excessive type I #IFN production & macrophages lytic death/necroptosis, allowing the differentiation of mature macrophages during bacterial infections! https://t.co/c9jKoGA7r3
IF staining of patient lungs confirmed the AT1 cell state. Interesting implications for unexpected repair pathways in lung and perhaps for diagnosis and therapy. @AJRCMB
Peer harmonized public #COVID19 vs control BAL #scRNAseq datasets to detect rare cell states in the infected #lung. Among his many findings was evidence for aberrant alveolar epithelial type 1 cells with cornification and other signatures reminiscent of the skin!
1/7 Latest paper in @CellStemCell! Transitional cell states sculpt tissue topology during lung regeneration. This work was jointly led by @arvikonk@KonishiSatoshi@TataAleksandra & Lauren with help from colleagues in our lab and collaborators @Duke https://t.co/CkxOqspF6u
Check out the line-up for the Gordon Research Conference on Immunometabolism! Excited to co-lead this with @LynnHedrickAU@PCHo_Lab & Nancie MacIver.
Mark your calendars--Registration is open!
https://t.co/BsSVD5TERn
This counters the longstanding paradigm of IRGM1 as an #interferongamma cell-autonomous antimicrobial protein. Exciting implications. Thanks to our collaborators @mayer_barber and Greg Taylor.